Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2021)
Hims & Hers Health (HIMS) posted Gains from Investment Securities of $2.7 million for Q1 2021, up 3876.06% sequentially from -$71000.0 in Q1 2020, and up 3876.06% YoY from $67428.6 in Q1 2020.
Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2021) Analysis & Trends
Hims & Hers Health has reported Gains from Investment Securities for 2 years, with the latest figure at $2.7 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2.68 Mn |
| Mar 31, 2021 | 2.68 Mn |
| Mar 31, 2020 | -71,000.00 |
| Mar 31, 2020 | -71,000.00 |